Latest Ventricular assist device Stories
FRAMINGHAM, Mass., March 7, 2014 /PRNewswire/ -- HeartWare International, Inc.
PLEASANTON, Calif., March 4, 2014 /PRNewswire/ -- On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials
AHA-Tucson Division Names SynCardia Co-Founder Copeland a Heart Hero for His Pioneering Work With Heart Transplants & the SynCardia Total Artificial Heart TUCSON, Ariz., March 4, 2014 /PRNewswire/
Researchers develop a bio-inspired actuated material that mimics the complex motion of the heart muscle and could lead to better implantable medical devices and flexible robots
FRAMINGHAM, Mass., Feb. 26, 2014 /PRNewswire/ -- HeartWare International, Inc.
PLEASANTON, Calif., Feb.
NEW YORK, Feb. 21, 2014 /PRNewswire/ -- Pomerantz LLP has filed a class action lawsuit against Thoratec Corporation ("Thoratec" or the "Company")(NASDAQ: THOR) and certain of its officers.
Sanger Heart & Vascular Institute achieves another regional first CHARLOTTE, N.C., Feb.
FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc.
- Revenue of $128.2 million for the fourth quarter of 2013 PLEASANTON, Calif., Feb.
The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...